Origins and functional basis of regulatory CD11c+CD8+ T cells

European Journal of Immunology

Volumn 39, Issue 6, 2009, Pages 1552-1563

  Vinay, Dass S ^a   Kim, Chang H ^b   Choi, Beom K ^b   Kwon, Byoung S ^b,c  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b National Cancer Center   (South Korea)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

4 1BB; CD11c+CD8+ T cells; Costimulation; IDO

Indexed keywords

CD137 ANTIGEN; CD8 ANTIGEN; ENZYME; GLYCOPROTEIN P 15095; TRYPTOPHAN; 1 METHYL TRYPTOPHAN; 1-METHYL-TRYPTOPHAN; DDIT3 PROTEIN, MOUSE; DRUG DERIVATIVE; EIF2AK4 PROTEIN, MOUSE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; INDOLEAMINE 2,3 DIOXYGENASE; LYMPHOCYTE ANTIGEN RECEPTOR; OVA 8; OVA-8; OVALBUMIN; PEPTIDE FRAGMENT; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD11C+ CD8+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELL MATURATION; CONTROLLED STUDY; CYTOLOGY; IMMUNE DEFICIENCY; IMMUNOCOMPETENT CELL; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL LINEAGE; CHEMICALLY INDUCED DISORDER; COLITIS; DENDRITIC CELL; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE MUTANT; SPLEEN; TRANSGENIC MOUSE; TRANSPLANTATION;

ANIMALS; ANTIGENS, CD11C; ANTIGENS, CD137; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINEAGE; COLITIS; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; IMMUNE TOLERANCE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; OVALBUMIN; PEPTIDE FRAGMENTS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, ANTIGEN, T-CELL; SPLEEN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTION FACTOR CHOP; TRYPTOPHAN;

EID: 67649531386     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200839057     Document Type: Article

References (28)

1. Le, N. T. and Chao, N., Regulating regulatory T cells. Bone Marrow Transplant. 2007. 39: 1-9.
2. Gershon, R. K. and Kondo, K., Infectious immunological tolerance. Immunology 1971. 21: 903-914.
3. Gilliet, M. and Liu, Y. J., Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 2002. 195: 695-704.
4. + suppressor T cells. J. Clin. Invest. 2004. 114: 1218-1221.
5. Xystrakis, E., Dejean, A. S., Bernard, I., Druet, P., Liblau, R., Daniel, G. D. and Saoudi, A., Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation. Blood 2004. 104: 3294-3301.
6. Vinay, D. S., Cha, K. and Kwon, B. S., Dual immunoregulatory pathways of 4-1BB signaling. J. Mol. Med. 2006. 84: 726-736.
7. Takahashi, C., Mittler, R. S. and Vella, A. T., 4-1BB is a bona fide CD8 T cell survival signal. J. Immunol. 1999. 162: 5037-5040.
8. Choi, B. K., Asai, T., Vinay, D. S., Kim, Y. H. and Kwon, B. S., 4-1BB-mediated amelioration of experimental autoimmune uveoretinitis is caused by indoleamine 2,3-dioxygenase-dependent mechanisms. Cytokine 2006. 34: 233-242.
9. Niu, L., Strahotin, S., Hewes, B., Zhang, B., Zhang, Y., Archer, D., Spencer, T. et al., Cytokine-mediated disruption of lymphocyte trafficking, hemopoiesis, and induction of lymphopenia, anemia, and thrombocytopenia in anti-CD137-treated mice. J. Immunol. 2007. 178: 4194-4213.
10. Seo, S. K., Choi, J. H., Kim, Y. H., Kang, W. J., Park, Y. H., Suh, J. H., Choi, B. K. et al., 4-1BB-mediated immunotherapy of rheumatoid arthritis. Nat. Med. 2004. 10: 1088-1094.
11. Sun, Y., Chen, H. M., Subudhi, S. K., Chen, J., Koka, R., Chen, L. and Fu, Y. X., Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease. Nat. Med. 2002. 8: 1405-1413.
12. Sun, Y., Blink, S. E., Chen, J. H. and Fu, Y. X., Regulation of follicular dendritic cell networks by activated T cells; the role of CD137 signaling. J. Immunol. 2005. 175: 884-890.
13. Vinay, D. S., Kim, J. D. and Kwon, B. S., Amelioration of mercury-induced autoimmunity by 4-1BB. J. Immunol. 2006. 177: 5708-5717.
14. Menoret, A., Myers, L. M., Lee, S. J., Mittler, R. S., Rossi, R. J. and Vella, A. T., TGFβ protein processing and activity through TCR triggering of primary CD8+ T regulatory cells. J. Immunol. 2006. 177: 6091-6097.
15. Myers, L., Croft, M., Kwon, B. S., Mittler, R. S. and Vella, A. T., Peptide-specific CD8 T regulatory cells use IFN-γ to elaborate TGF-β-based suppression. J. Immunol. 2005. 174: 625-7632.
16. + T cells. Cell. Immunol. 2005. 238: 76-86.
17. Lee, J., Lee, E. N., Kim, E. Y., Park, H. J., Chang, C. Y., Jung, D. X., Choi, S. Y. et al., Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease. Immunol. Lett. 2005. 101: 210-216.
18. + T-cell-mediated inflammatory colitis. Clin. Exp. Immunol. 2006. 143: 228-236.
19. + T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/ HeJBir mice: Increased T helper cell type 1 response and ability to transfer disease. J. Exp. Med. 1998. 16: 855-864.
20. + T cells requires CD40-CD40 ligand interactions for a sustained increase in mucosal IL-12. J. Immunol. 2000. 165: 2173-2182.
21. Stronkhorst, A., Radema, S., Yong, S. L., Bijl, H., Ten Berge, I. J., Tytgat, G. N. and van Deventer, S. J., CD4 antibody treatment in patients with active Crohn's disease: A phase 1 dose finding study. Gut 1997. 40: 320-327.
22. Sharma, M. D., Baban, B., Chandler, P., Hou, D. Y., Singh, N., Yagita, H., Azuma, M. et al., Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J. Clin. Invest. 2007. 117: 570-582.
23. Munn, D. H., Sharma, M. D., Baban, B., Harding, H. P., Zhang, Y., Ron, D. and Mellor, A. L., GCN2 kinase in T cell mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 2005. 22: 633-642.
24. Aguague, S., Perrin-Cocon, L., Coutant, F., Andre, P. and Lotteau, V., 1-methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity. J. Immunol. 2006. 177: 2061-2071.
25. Vinay, D. S. and Kwon, B. S., Regulatory CD8+ T cells, in: Xiang, J. (Ed.), Recent Development in Immunology, Transworld Res Network, India 2008, pp. 57-71.
26. Mellor, A. L. and Munn, D. H., Tryptophan catabolism and regulation of adoptive immunity. J. Immunol. 2003. 170: 5809-5813.
27. Kwon, B. S., Hurtado, J. C., Lee, J. H., Kwack, K. B., Seo, S. K., Choi, B. K., Koller, B. H. et al., Immune responses in 4-1BB (CD137)-deficient mice. J. Immunol. 2002. 168: 5483-5490.
28. Elson, C. O., Beagley, B. W., Sharmanov, A. T., Fujihashi, K., Kiyono, H., Tennyson, G. S., Cong, Y. et al., Hapten-induced model of murine inflammatory bowel disease: Mucosal immune responses and protection by tolerance. J. Immunol. 1996. 157: 2174-2185.